MUC1 and cancer: The binding of MGL to the truncated glycan structures on MUC1 leads to a defective T-helper (Th) cell-mediated response as well as to a reduction of cytotoxic T lymphocytes (CTLs) [22], which are usually able to recognize foreign antigens presented via MHCI and eliminate cancer cells [31].